Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
Eilam Yeini, Paula Ofek, Nitzan Albeck, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment
Lena Neufeld, Eilam Yeini, Noa Reisman, et al.
Science Advances (2021) Vol. 7, Iss. 34
Open Access | Times Cited: 138
Recent advances in drug delivery systems for targeting brain tumors
Yi Zhao, Ping Yue, Yao Peng, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 45
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
Elza Neelima Mathew, Bethany C. Berry, Hong Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1711-1711
Open Access | Times Cited: 56
Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
Monika Kaurav, Sakina Ruhi, Husni Ahmed Al-Goshae, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
Nerea Iturrioz-Rodríguez, Nicolás Samprón, Ander Matheu
Theranostics (2023) Vol. 13, Iss. 9, pp. 2734-2756
Open Access | Times Cited: 29
Drug Delivery to the Brain: Recent Advances and Unmet Challenges
Sukanya Bhunia, Nagesh Kolishetti, Arti Vashist, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2658-2658
Open Access | Times Cited: 24
Exosome-Coated Prussian Blue Nanoparticles for Specific Targeting and Treatment of Glioblastoma
Meghan Hill, Seock‐Jin Chung, Hyun‐Joo Woo, et al.
ACS Applied Materials & Interfaces (2024)
Open Access | Times Cited: 11
Recent advances in targeted drug delivery for the treatment of glioblastoma
Meng Mao, Yingjie Wu, Qiang He
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8689-8707
Closed Access | Times Cited: 9
Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?
Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113760-113760
Closed Access | Times Cited: 47
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Leonardo Delello Di Filippo, Juliana H. Azambuja, Jessyca Aparecida Paes Dutra, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 168, pp. 76-89
Closed Access | Times Cited: 46
Image‐guided diagnosis and treatment of glioblastoma
Yongning Bian, Yaling Wang, Xueqian Chen, et al.
View (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 20
Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma
Perpetue Bataille Backer, Tayo Alex Adekiya, Yushin Kim, et al.
ACS Omega (2024) Vol. 9, Iss. 2, pp. 2615-2628
Open Access | Times Cited: 7
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells
Arianna Rinaldi, Florence Dumas, Jason Thomas Duskey, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123994-123994
Closed Access | Times Cited: 6
Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 494-513
Closed Access | Times Cited: 26
Exosomes; multifaceted nanoplatform for targeting brain cancers
Narges Mardi, Fatemeh Salahpour‐Anarjan, Mahdieh Nemati, et al.
Cancer Letters (2023) Vol. 557, pp. 216077-216077
Closed Access | Times Cited: 16
Highlights in targeted nanoparticles as a delivery strategy for glioma treatment
Marcela Tavares Luiz, Leonardo Delello Di Filippo, Larissa Bueno Tofani, et al.
International Journal of Pharmaceutics (2021) Vol. 604, pp. 120758-120758
Open Access | Times Cited: 30
Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
Changcan Li, Bao Jin, Hang Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Daniel Ruiz‐Molina, Xiaoman Mao, Paula Alfonso-Triguero, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4960-4960
Open Access | Times Cited: 20
Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
Adip G. Bhargav, Joseph S. Domino, Roukoz Chamoun, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 19
Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub‐5 Ultrafine Iron Oxide Nanoparticles
Yuancheng Li, Manman Xie, Joshua B. Jones, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 19
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Jonatas Lobato Duarte, et al.
Materials Today Bio (2023) Vol. 20, pp. 100671-100671
Open Access | Times Cited: 12
Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105980-105980
Open Access | Times Cited: 4
State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment
Mehrnaz Mostafavi, Farhood Ghazi, Mahboobeh Mehrabifard, et al.
Strahlentherapie und Onkologie (2024)
Open Access | Times Cited: 4
Ph-Responsive Chitosan-Sodium Alginate Nanocarriers for Curcumin Delivery Against Brain Cancer
Pablo Taboada Antelo, Matin Mahmoudifard, Mehrab Pourmadadi, et al.
(2025)
Closed Access
The clinicopathologic and prognostic value of CD44 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis
Elmira Alaei, Najma Farahani, Sima Orouei, et al.
Molecular and Cellular Probes (2025), pp. 102028-102028
Open Access
Page 1 - Next Page

Scroll to top